JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
INTI - Inhibitor Therapeutics, Inc.
USD | OTC Markets | Healthcare
Summary
Summary INTI Stock
Financials
Financials INTI Stock
Loading...
Loading...
Income Statement
Income Statement INTI Stock
Balance Sheet
Balance Sheet INTI Stock
Cash Flow Statement
Cash Flow Statement INTI Stock
Loading...
Loading...
Home
Stocks
Inhibitor Therapeutics, Inc. (INTI)
Financials
Financials of INTI
Loading...
Loading...
Loading...
Loading...
INTI Financials - Inhibitor Therapeutics Income & Cash Flow | Ledgeburg
Revenue
N/A
Operating Income
$-3.426653M
Net Income
$-3.300337M
Share Count (Basic)
172.511901M
Operating Cash Flow
$-3.23137M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$2.375493M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
FY2021
Revenue $USD
No data available
Annual
Quarterly
Net Income $USD
0
5M
10M
FY2021
Annual
Quarterly
Margins
No data available
Margins
No data available
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-1.2M
-1M
-800K
-600K
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26